Dr. Reddy's Laboratories Ltd
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of partial seizures (either as monotherapy or as an adjunct therapy) in adults and children aged 6 years and older.
Dosage form: tablets
Active substance Dosage eslicarbazepine acetate 200 mg ATC: N03AF04
-
The drug is used for the treatment of partial seizures (as monotherapy in adults with newly diagnosed epilepsy, or as adjunctive therapy in adults and children aged 6 years and older).
Dosage form: tablets
Active substance Dosage eslicarbazepine acetate 400 mg ATC: N03AF04
-
The drug is used for the treatment of partial seizures (as monotherapy in adults with newly diagnosed epilepsy, or as adjunctive therapy in adults and children aged 6 years and older).
Dosage form: tablets
Active substance Dosage eslicarbazepine acetate 800 mg ATC: N03AF04
-
It is used to reduce the duration and frequency of neutropenia (a decrease in neutrophil levels) in patients undergoing chemotherapy or bone marrow transplantation. It is also used for hematopoietic stem cell mobilization, the treatment of persistent neutropenia in HIV infection, and in certain hereditary disorders.
Dosage form: solution for injection
Active substance Dosage human granulocyte colony stimulating factor 0.3 mg/ml ATC: L03AA02
-
The drug is used to treat certain types of blood cancer, specifically non-Hodgkin lymphomas and chronic lymphocytic leukemia. It is also used to induce remission in severe forms of granulomatosis with polyangiitis and microscopic polyangiitis.
Dosage form: concentrate for infusion solution
Active substance Dosage rituximab 10 mg/ml ATC: L01XC02
-
The drug is prescribed for the treatment of arterial hypertension (high blood pressure), especially in cases where blood pressure is not sufficiently controlled with telmisartan alone.
Dosage form: tablets
Active substance Dosage telmisartan 80 mg hydrochlorothiazide 12.5 mg ATC: C09DA07
-
The drug is prescribed for the treatment of various types of cancer, including metastatic colorectal cancer, non-small cell lung cancer, recurrent glioblastoma, renal cell carcinoma, cervical cancer, and metastatic breast cancer.
Dosage form: concentrate for infusion solution
Active substance Dosage bevacizumab 25 mg/ml ATC: L01FG01